Further statistical analyses showed that patients with hepatitis B and a high alpha-fetoprotein (AFP) level in serum (>200 ng/mL) showed a higher efficacy from Lenvatinib compared to Sorafenib [39,60,65]. Here, AFP is linked to hepatitis B virus infection.